Tenon Medical, Inc. (TNON)
| Market Cap | 3.34M -71.3% |
| Revenue (ttm) | 5.31M +80.3% |
| Net Income | -13.70M |
| EPS | -46.67 |
| Shares Out | 667.05K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,755,580 |
| Open | 5.46 |
| Previous Close | 5.02 |
| Day's Range | 4.75 - 5.62 |
| 52-Week Range | 4.38 - 50.40 |
| Beta | 1.40 |
| Analysts | Buy |
| Price Target | 44.38 (+787.6%) |
| Earnings Date | Aug 13, 2026 |
About TNON
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along it... [Read more]
Financial Performance
In 2025, Tenon Medical's revenue was $3.94 million, an increase of 20.35% compared to the previous year's $3.28 million. Losses were -$12.56 million, -8.17% less than in 2024.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for TNON stock is "Buy." The 12-month stock price target is $44.38, which is an increase of 787.60% from the latest price.
News
Tenon Medical announces $3M private placement
WallachBeth Capital announced that on August 27, Tenon Medical (TNON) has entered into a securities purchase agreement with an institutional investor to sell 597,610 shares of common stock, together w...
WallachBeth Capital Announces Tenon Medical Pricing of $3M Private Placement Offering
JERSEY CITY, N.J., Aug. 28, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that on August 27, 2026, Tenon Medical, ...
Tenon Medical Announces Pricing of $3M Private Placement Offering
LOS GATOS, CA / ACCESS Newswire / August 28, 2026 / Tenon Medical, Inc. (NASDAQ:TNON), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today a...
Tenon Medical regains compliance with Nasdaq minimum bid price requirement
Tenon Medical (TNON) announced that it has received notice from The Nasdaq Stock Market, confirming that the company has regained compliance with the minimum bid price requirement. Published first on…
Tenon Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
LOS GATOS, CA / ACCESS Newswire / August 24, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacr...
Tenon Medical Inc trading resumes
09:45 EDT Tenon Medical (TNON) Inc trading resumes
Tenon Medical Inc trading halted, volatility trading pause
09:40 EDT Tenon Medical (TNON) Inc trading halted, volatility trading pause
Tenon Medical Registration statement: Registration filing
Tenon Medical filed a registration statement on August 17, 2026, providing details about a securities offering with the SEC.
Tenon Medical files $100M mixed securities shelf
17:32 EDT Tenon Medical (TNON) files $100M mixed securities shelf
Tenon Medical Earnings Call Transcript: Q2 2026
Revenue and gross profit more than doubled year-over-year, with gross margin expanding to 64%. Key product enhancements and FDA clearance are expected to drive further growth, supported by a recent $4.2 million capital raise and strong physician engagement.
Tenon Medical Earnings release: Q2 2026
Tenon Medical released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
Tenon Medical Quarterly report: Q2 2026
Tenon Medical has published its Q2 2026 quarterly earnings report on August 13, 2026.
Tenon Medical Reports Second Quarter 2026 Financial Results
~ Second Quarter 2026 Revenue of $1.3 Million, a 127% Increase Compared to Prior Year ~ ~ Second Quarter Gross Profit of $0.8 Million, a 232% Increase Compared to Prior Year; Gross Margin of 64% ~ ~ R...
Tenon Medical Registration statement: Registration filing
Tenon Medical filed a registration statement on August 11, 2026, providing details about a securities offering with the SEC.
Tenon Medical Inc trading halted, news pending
19:50 EDT Tenon Medical (TNON) Inc trading halted, news pending
Tenon Medical announces 1-for-35 reverse stock split
Tenon Medical (TNON) announced a 1-for-35 reverse stock split of the Company’s issued and outstanding common stock. The reverse stock split will become effective on August 10, 2026, prior to…
Tenon Medical, Inc. Announces 1:35 Reverse Stock Split
LOS GATOS, CA / ACCESS Newswire / August 6, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro...
Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings
LOS GATOS, CA / ACCESS Newswire / July 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON)("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-p...
Tenon Medical Transcript: AGM 2026
The meeting covered board introductions, voting on six key proposals, and provided a Q&A session. All director nominees and proposals were approved, with results to be filed with the SEC. No questions were raised by stockholders during the session.
Tenon Medical regains compliance with Nasdaq stockholders’ equity requirement
Tenon Medical (TNON) announced that it has received notice from Nasdaq that the Company regained compliance with the continued listing requirement relating to maintaining a minimum of $2.5M in stockho...
Tenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity Requirement
LOS GATOS, CA / ACCESS Newswire / July 20, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-...
Tenon Medical Proxy statement: Proxy filing
Tenon Medical filed a proxy statement on July 13, 2026, providing details for shareholder voting and corporate governance matters.
Tenon Medical announces FDA 510k clearance for Catamaran system
Tenon Medical (TNON) announced it has received U.S. Food and Drug Administration, FDA, 510(k) clearance for its Catamaran SI Joint Fusion System. The updated clearance incorporates various instrument ...
Tenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion System
~ Updated clearance incorporates various instrument upgrades, as well as per-procedure costs, improving unit economics driven by the reclassification of certain instruments from disposable to reusable...
WallachBeth Capital Announces Closing of Tenon Medical, Inc. $4.2 Million Public Offering
JERSEY CITY, N.J., July 1, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ: T...